Moxifloxacin/prednisolone ophthalmic suspension

moxifloxacin/prednisolone · Adapt Produtos Oftalmológicos Ltda

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Moxifloxacin/prednisolone ophthalmic suspension, covering 2012-05-22 to 2012-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Moxifloxacin/Prednisolone in Prevention of Post Surgery Inflammation [Phase 3]